https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-nomination-committee-ahead-of-the-2027-annual-general-meeting 2026-10-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-invites-to-an-investor-and-scientific-update-in-stockholm-and-gothenburg-on-november-12-and-13-respectively 2026-10-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-to-present-at-upcoming-investor-meetings 2026-09-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-june-2026 2026-08-25 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-expands-the-number-of-study-sites-to-accelerate-patient-recruitment-in-cancer-study 2026-08-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-initiates-last-dose-cohort-in-ongoing-phase-ib-study-with-arfolitixorin 2026-07-08 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-19-may-2026 2026-05-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-march-2026 2026-05-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=new-number-of-shares-and-votes-in-isofol-1 2026-04-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=notice-to-attend-the-annual-general-meeting-held-on-may-19-2026-in-isofol-medical-ab-publ-1 2026-04-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-optimizes-the-design-of-its-phase-ib-ii-study-following-new-regulatory-approval 2026-04-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2025 2026-04-10 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-gross-proceeds-of-18-9-msek-in-connection-with-the-exercise-of-warrants-and-guarantee-commitments-for-warrants-of-series-to1-and-resolves-on-a-directed-share-issue 2026-03-31 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-secures-license-rights-for-arfolitixorin-in-autism 2026-03-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=the-subscription-price-for-warrants-of-series-to1-in-isofol-has-been-set-at-sek-0-48-and-the-exercise-period-commences-on-16-march-2026 2026-03-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-top-guarantee-commitment-and-letters-of-intent-corresponding-to-42-percent-of-upcoming-warrant-exercise 2026-03-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-nomination-committee-proposes-election-of-christian-haglund-as-new-board-director 2026-03-09 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-presents-at-investor-meetings-in-march 2026-03-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-provides-update-on-the-ongoing-phase-ib-ii-clinical-study-of-arfolitixorin 2026-02-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-year-end-report-january-december-2025 2026-02-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-participates-in-the-asco-gi-congress 2026-01-09 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-participates-in-several-investor-meetings-in-december-and-january 2025-12-01 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=european-patent-office-intends-to-grant-a-new-patent-for-isofols-arfolitixorin 2025-11-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-september-2025 2025-11-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2026 2025-11-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-invites-to-an-investor-meeting-on-november-13-2025 2025-10-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-participates-in-the-esmo-cancer-congress 2025-10-16 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-clinical-study-with-arfolitixorin-reaches-another-important-milestone 2025-09-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-completes-transfer-of-shares-to-solasia-pharma-following-a-successful-rights-issue 2025-09-26 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-june-2025 2025-08-26 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-invites-to-a-presentation-of-the-interim-report-for-the-second-quarter-2025 2025-08-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=new-number-of-shares-and-votes-in-isofol 2025-07-31 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-successfully-completes-pre-ind-meeting-with-the-fda-for-arfolitixorin 2025-07-16 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-rights-issue-fully-subscribed-exercises-overallotment-for-japanese-partner 2025-07-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-publishes-prospectus-in-connection-with-the-companys-rights-issue 2025-06-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-completes-first-cohort-in-ongoing-clinical-study-with-arfolitixorin 2025-06-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-11-june-2025 2025-06-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-final-terms-of-the-rights-issue-and-the-potential-overallotment-issue 2025-06-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-the-launch-of-new-advisory-board-in-connection-with-asco-2025 2025-06-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-granted-pre-ind-meeting-with-the-fda-for-arfolitixorin 2025-06-02 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-21-2025 2025-05-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-march-2025 2025-05-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=interview-with-isofols-ceo-petter-segelman-lindqvist-on-upcoming-rights-issue 2025-05-14 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=notice-to-attend-the-extraordinary-general-meeting-held-on-june-11-2025-in-isofol-medical-ab-publ 2025-05-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=the-board-of-directors-of-isofol-resolves-on-a-fully-guaranteed-rights-issue-of-units-amounting-to-approximately-sek-85-million-and-proposes-an-over-allotment-issue-of-approximately-sek-10-million 2025-05-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-includes-first-patient-in-a-clinical-phase-ib-ii-study-of-arfolitixorin 2025-04-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=notice-to-attend-the-annual-general-meeting-held-on-may-21-2025-in-isofol-medical-ab-publ-1 2025-04-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2024 2025-04-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-partner-solasia-intends-to-increase-investments-in-upcoming-trials-with-arfolitixorin 2025-04-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-establish-advisory-board-with-leading-experts 2025-03-27 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-regulatory-approval-to-initiate-clinical-study-of-arfolitixorin 2025-03-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-expands-network-of-advisors-with-prominent-expert 2025-03-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-presents-at-stora-aktiedagarna-on-march-12 2025-03-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-presents-at-several-upcoming-investor-meetings 2025-03-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-year-end-report-january-december-2024 2025-02-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-roger-tell-as-chief-medical-officer-ahead-of-initiation-of-clinical-study 2025-02-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-the-presentation-of-a-post-hoc-analysis-of-the-phase-iii-study-agent-at-the-2025-asco-gi-symposium 2025-01-27 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-and-its-partner-solasia-plan-to-expand-the-upcoming-clinical-trial-of-arfolitixorin-to-japan 2024-12-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-an-investigator-initiated-study-of-arfolitixorin-has-been-published-in-bjc-reports 2024-11-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-provides-an-operational-update-during-investor-meeting 2024-11-20 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2025 2024-11-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-september-2024 2024-11-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-an-abstract-has-been-accepted-for-presentation-at-asco-gi-2025 2024-11-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-invites-to-investor-meeting-on-november-20-2024 2024-10-25 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=a-late-breaking-abstract-concerning-arfolitixorin-will-be-presented-at-ena-2024-today 2024-10-23 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-a-late-breaking-abstract-has-been-accepted-by-ena-2024 2024-10-09 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-strengthens-the-outlook-for-further-extending-the-patent-protection-of-its-drug-candidate-arfolitixorin 2024-09-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-terminates-liquidity-guarantee-agreement 2024-09-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-june-2024 2024-08-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-magdalena-hagman-as-new-chief-financial-officer 2024-07-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-new-preclinical-data-supporting-the-previously-communicated-clinical-development-plan-for-arfolitixorin 2024-07-16 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-a-post-hoc-per-protocol-analysis-of-the-agent-study-further-supporting-arfolitixorins-continued-clinical-development 2024-07-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-chief-financial-officer-to-leave-the-company 2024-06-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-and-charite-sign-collaboration-agreement-on-further-clinical-development-of-arfolitixorin 2024-05-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-8-2024 2024-05-08 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-march-2024 2024-05-08 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2023 2024-04-16 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=notice-to-attend-the-annual-general-meeting-held-on-may-8-2024-in-isofol-medical-ab-publ 2024-04-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-japanese-partner-solasia-intensifies-its-commitment-to-the-clinical-development-of-arfolitixorin 2024-03-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-presents-a-clinical-development-plan-for-arfolitixorin 2024-03-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-invites-to-investor-meeting-on-march-19 2024-03-01 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-year-end-report-january-december-2023-1aa5f5e8 2024-02-20 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-board-of-directors-decides-to-initiate-the-planning-of-clinical-studies-and-will-announce-a-strategic-development-plan-on-march-19-a260f016 2024-02-14 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-magnus-hurst-as-new-chief-financial-officer-2ac8c3ce 2024-01-10 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-petter-segelman-lindqvist-as-new-ceo-7968664d 2024-01-09 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-january-4-2024-dc47edff 2024-01-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-presents-additional-results-from-laboratory-tests-with-arfolitixorin-showing-supplementary-effects-4d28abea 2023-12-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-board-of-directors-announces-its-position-on-minority-shareholders-proposal-ahead-of-extraordinary-general-meeting-6f0d76c8 2023-12-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-has-received-the-first-results-from-laboratory-tests-of-arfolitixorin-d52a3da9 2023-12-07 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-is-liquidating-a-subsidiary-d3085941 2023-12-01 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=notice-convening-the-extraordinary-general-meeting-in-isofol-medical-ab-publ-4-january-2024-9342bc18 2023-11-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-september-2023-f26ae54c 2023-11-10 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-has-obtained-a-request-to-call-an-extraordinary-general-meeting-2696a264 2023-11-09 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2024-3f36e529 2023-11-08 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-has-taken-note-of-the-results-from-the-modelle-001-study-5616c589 2023-10-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-june-2023-2af51282 2023-08-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-presents-conclusions-from-the-in-depth-analysis-of-the-agent-study-04b00b18 2023-07-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-board-of-directors-appoints-roger-tell-as-acting-ceo-of-the-company-ebe85a24 2023-06-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=ceo-resigns-at-his-own-request-in-isofol-medical-ab-publ-6649e731 2023-06-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=changes-in-the-board-at-isofol-medical-ab-publ-2dce53a9 2023-06-07 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-3-2023-b2db52cf 2023-05-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-march-2023-32e1a591 2023-05-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-initiates-preclinical-evaluation-of-arfolitixorin-with-oncosyne-as-d3ff23e7 2023-04-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-presentation-of-isofol-s-report-for-the-first-quarter-of-2023-23a53b59 2023-04-25 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2022-e22469c9 2023-04-06 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-appoints-roy-jonebrant-as-new-acting-chief-financial-officer-5418fe8a 2023-03-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-initiates-a-stepwise-process-for-the-continued-development-of-its-drug-candidate-arfolitixorin-29535090 2023-03-06 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-board-appoints-thomas-andersson-as-new-ceo-of-the-company-bef7dd6a 2023-02-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-february-28-2023-8fa8468f 2023-02-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-year-end-report-january-december-2022-7514431f 2023-02-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-extraordinary-general-meeting-in-isofol-medical-ab-publ-held-on-february-13-2023-048aef52 2023-02-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-presentation-of-isofol-s-report-for-the-fourth-quarter-of-2022-dfd24a29 2023-02-09 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-has-obtained-a-request-to-call-for-an-extraordinary-general-meeting-10cc404e 2023-01-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-invites-to-an-informational-meeting-on-january-30-prior-to-extraordinary-general-meeting-68289a51 2023-01-20 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=notice-convening-the-extraordinary-general-meeting-in-isofol-medical-ab-publ-13-february-2023-6563cc07 2023-01-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medicals-board-of-directors-intends-to-call-an-extraordinary-general-meeting-with-proposals-for-dividends-and-liquidation-of-the-company-44ce85a2 2023-01-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-cfo-and-deputy-ceo-gustaf-albert-to-step-down-during-2023-1453204a 2022-12-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=ceo-ulf-jungnelius-to-leave-isofol-medical-on-june-1-2023-5ad03d14 2022-11-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=final-data-from-the-agent-study-confirms-topline-results-1b80bde1 2022-11-25 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-september-2022-c4f89151 2022-11-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2023-dbe94182 2022-11-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-presentation-of-isofols-report-for-the-third-quarter-of-2022-1ad90c40 2022-10-27 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reports-data-from-the-agent-study-5449e396 2022-09-07 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-provides-update-on-the-agent-study-800425ad 2022-08-31 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-june-2022-a42e294e 2022-08-23 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-presentation-of-isofol-s-report-for-the-second-quarter-of-2022-a9253868 2022-08-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-topline-results-of-phase-iii-agent-study-did-not-meet-primary-or-key-secondary-endpoints-da77d5fe 2022-08-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-approval-of-biomarker-analysis-patent-and-intention-to-grant-patent-application-for-study-dose-regimen-in-europe-db0cfcdb 2022-07-26 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-updates-start-time-of-live-streamed-randd-event-on-june-20-to-14-00-cest-d0375f5f 2022-06-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-invites-to-a-live-streamed-randd-event-on-june-20-at-12-30-cest-15feddcd 2022-06-14 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-may-19-2022-c5f97468 2022-05-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-january-march-2022-72224e9e 2022-05-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-presentation-of-isofols-report-for-the-first-quarter-of-2022-602cff76 2022-05-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-annual-report-and-corporate-governance-report-for-2021-d0c24af2 2022-04-27 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-start-of-study-data-analysis-of-phase-iii-agent-study-in-advanced-metastatic-colorectal-cancer-056a03da 2022-04-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=notice-to-attend-the-annual-general-meeting-held-on-may-19-2022-in-isofol-medical-ab-publ-75b5d8ac 2022-04-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-abs-publ-nomination-committee-proposes-new-chair-of-the-board-5bcaaa45 2022-04-08 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-year-end-report-january-december-2021-3a033ca9 2022-02-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-presentation-of-isofols-year-end-report-2021-on-february-24-2022-d9cb969f 2022-02-14 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-recognizes-world-cancer-day-on-february-4-3808cddf 2022-02-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-appoints-jenny-sundqvist-as-chief-commercial-officer-39f308e1 2021-12-10 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-invites-to-an-audiocast-on-december-6-at-08-00-a-m-cet-33b572cd 2021-12-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-will-not-reach-300-pfs-events-in-the-agent-study-with-current-censoring-rules-based-on-fda-decision-211d838b 2021-12-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-receives-fda-fast-track-designation-for-arfolitixorin-in-advanced-colorectal-cancer-mcrc-d9d2c112 2021-11-23 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-nomination-committee-ahead-of-the-annual-general-meeting-2022-b1912074 2021-11-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-interim-report-for-january-september-2021-af8a1abc 2021-11-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=trading-in-isofols-shares-commences-today-on-nasdaq-stockholm-07d381a3 2021-10-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-publishes-prospectus-and-new-financial-information-in-connection-with-listing-on-nasdaq-stockholm-bac755db 2021-10-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-intends-to-list-its-shares-on-nasdaq-stockholm-97b03351 2021-10-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=company-presentation-at-lsx-nordic-congress-2021-413db263 2021-09-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=bulletin-from-annual-general-meeting-in-isofol-medical-ab-publ-held-on-june-23-2021-6136a395 2021-06-23 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-raises-sek-500-million-in-oversubscribed-rights-issue-and-exercised-over-allotment-option-bc47cb4d 2021-06-14 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-publishes-prospectus-in-connection-with-the-fully-guaranteed-preferential-rights-issue-of-approximately-sek-400-million-ae211b72 2021-05-25 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-board-of-directors-resolves-on-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-400-million-25205673 2021-05-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-completes-recruitment-of-japanese-patients-in-the-global-phase-iii-agent-study-0cb7a751 2021-05-06 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-its-intention-to-carry-out-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-400-million-and-a-potential-over-allotment-option-of-up-to-approximately-sek-100-million-6f0c04a6 2021-04-28 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-notice-that-clinical-use-patent-in-europe-for-drug-candidate-arfolitixorin-will-be-approved-b1e09707 2021-03-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-a-conference-call-and-webcast-in-connection-with-isofol-receiving-recommendation-to-complete-the-global-phase-iii-agent-study-for-market-registration-as-planned-with-440-patients-2ab12d50 2021-03-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-recommendation-from-idsmb-to-complete-the-global-phase-iii-agent-study-for-market-registration-as-planned-with-440-patients-c0cd9cec 2021-03-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-to-present-gene-expression-results-from-the-completed-phase-i-iia-iso-cc-005-study-today-at-asco-gi-2021-and-updates-of-the-timing-of-the-interim-analysis-in-the-agent-study-fb788dde 2021-01-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reaches-440-patients-in-global-phase-iii-agent-study-d852d8a8 2020-12-09 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-a-conference-call-and-webcast-by-isofol-in-connection-with-the-entered-license-agreement-for-paladin-labs-inc-to-commercialize-arfolitixorin-in-canada-20a8abef 2020-11-02 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-licensing-agreement-for-paladin-labs-inc-to-commercialize-arfolitixorin-in-canada-a89f672d 2020-11-02 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=55-overall-response-rate-on-the-safety-extension-cohorts-of-the-iso-cc-005-phase-i-iia-study-6f828e7d 2020-09-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=strengthened-patent-protection-for-arfolitixorin-in-japan-7be2553b 2020-09-01 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-to-a-conference-call-and-webcast-by-isofol-in-connection-with-the-entered-license-agreement-with-solasia-5f54828e 2020-08-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-enters-licensing-agreement-with-solasia-to-develop-and-commercialize-arfolitixorin-in-japan-6854344d 2020-08-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-ceo-ulf-jungnelius-has-subscribed-for-all-warrants-430a860c 2020-08-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=a-milestone-is-reached-with-the-inclusion-of-330-patients-in-the-agent-study-opening-up-for-the-interim-analysis-c62cca61 2020-07-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=agent-study-update-with-regards-to-covid-19-3eec05b7 2020-07-10 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-rights-issue-oversubscribed-e74ca95a 2020-06-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=consortium-of-investors-acquires-subscription-rights-from-isofol-s-founder-professor-bengt-gustavsson-55391ffa 2020-05-29 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-publishes-prospectus-in-connection-with-the-fully-guaranteed-preferential-rights-issue-of-approximately-sek-150-million-e94473d0 2020-05-14 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-board-of-directors-resolve-on-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-150-million-992ce10d 2020-05-07 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-drug-candidate-arfolitixorin-receives-additional-clinical-patent-approval-in-the-united-states-d535b8c7 2020-05-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=information-in-relation-to-covid-19-67a9e418 2020-04-02 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=gene-expression-data-from-new-analysis-method-supports-that-a-larger-proportion-of-patients-will-benefit-from-arfolitixorin-53a1adea 2020-03-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-its-intention-to-carry-out-a-fully-guaranteed-preferential-rights-issue-of-approximately-sek-150-million-and-a-potential-over-allotment-option-of-up-to-approximately-sek-30-million-d53bde3a 2020-03-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=the-first-patient-included-in-japan-in-isofols-phase-3-agent-study-f2a4029c 2020-02-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=gene-expression-analysis-method-has-been-validated-by-a-commercial-laboratory-ded8d438 2020-01-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=over-200-patients-now-randomized-in-the-global-phase-3-agent-study-cbe8e01e 2020-01-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=the-phase-1-2a-study-iso-cc-005-is-completed-8136a7f3 2020-01-30 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=the-first-patient-included-in-australia-in-isofols-phase-3-agent-study-6a1dd2c2 2020-01-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=patent-approved-in-japan-for-isofols-drug-candidate-arfolitixorin-81de543b 2019-12-20 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=patent-detecting-how-patients-respond-to-folate-based-cancer-treatment-approved-in-the-usa-1067fc1e 2019-12-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-to-expand-global-phase-3-agent-trial-in-first-line-metastatic-colorectal-cancer-to-australia-8574ae61 2019-11-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-board-appoints-dr-jarl-ulf-jungnelius-as-new-ceo-of-the-company-098c51ac 2019-11-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-positive-feedback-from-pmda-in-japan-expanding-ongoing-global-pivotal-phase-3-agent-trial-in-first-line-metastatic-colorectal-cancer-f1d9ba26 2019-10-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-presentation-on-the-global-phase-3-study-of-arfolitixorin-in-metastatic-colorectal-cancer-at-2019-esmo-congress-52e61c64 2019-09-29 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-an-abstract-has-been-accepted-for-presentation-at-the-2019-esmo-congress-e25ce594 2019-09-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-management-team-evolution-with-appointment-of-dr-roger-tell-as-chief-medical-officer-d6b05497 2019-08-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-recent-advisory-board-meeting-covering-development-plan-for-arfolitixorin-ccd44b4f 2019-07-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-receives-clinical-use-patent-approval-in-the-united-states-for-drug-candidate-arfolitixorin-00a0052e 2019-06-25 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-election-of-three-new-board-members-65b50a26 2019-06-10 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-drug-candidate-arfolitixorin-receives-clinical-patent-approval-in-the-united-states-7f0e698a 2019-05-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reports-58-overall-response-rate-in-patients-with-metastatic-colorectal-cancer-in-phase-1-2a-open-label-extension-study-with-arfolitixorin-c6ba80f3 2019-05-08 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-ab-publ-appoints-carnegie-investment-bank-ab-publ-to-financial-advisor-2a6f4923 2019-02-27 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reports-all-employees-participate-in-newly-created-share-warrant-program-bbb55d12 2019-02-01 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-has-participated-in-the-empowered-patient-podcast-50b200b2 2019-01-31 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reports-early-tumor-shrinkage-in-patients-with-colorectal-cancer-in-phase-1-2a-open-label-extension-study-with-arfolitixorin-0d3262ca 2019-01-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=first-patient-enrolled-in-isofols-pivotal-phase-3-agent-study-in-1st-line-metastatic-colorectal-cancer-d418bbdf 2018-12-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-strengthens-executive-management-team-with-the-appointment-of-roger-tell-md-phd-as-chief-scientific-officer-and-senior-vice-president-of-clinical-development-a4db66f2 2018-11-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-the-appointment-of-robert-marchesani-as-an-advisor-to-its-board-of-directors-85ce16b0 2018-11-16 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-initiation-of-a-pivotal-phase-3-clinical-trial-of-arfolitixorin-for-the-treatment-of-metastatic-colorectal-cancer-582ca905 2018-11-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=new-chairman-and-extended-board-at-isofol-medical-ab-publ-b8c74d50 2018-09-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=patent-approved-in-the-united-states-for-isofols-drug-candidate-arfolitixorin-bb84c0b5 2018-08-31 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=redeye-and-isofol-are-inviting-to-the-live-broadcast-of-pre-asco-on-may-28th-137b93ca 2018-05-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-an-abstract-with-new-research-resultshas-been-published-for-this-years-asco-congress-in-chicago-b5b45b1d 2018-05-15 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reports-fdas-feedback-from-the-ongoing-special-protocol-assessment-spa-process-bd39a792 2018-05-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-an-abstract-describing-a-genetic-prediction-of-treatment-response-in-crc-treatment-to-be-unveiled-at-asco-2018-212d6d13 2018-04-10 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-has-selected-arfolitixorin-dose-for-the-phase-iii-pivotal-study-iso-cc-007-1c7543ec 2018-03-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-adopts-the-world-health-organization-recommended-name-inn-arfolitixorin-for-modufolin-r-695c29e8 2018-02-19 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reports-successful-outcome-from-the-scientific-advice-with-the-ema-a52a0796 2018-02-08 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-ceo-directors-and-employees-converts-stock-and-employee-options-and-subscribe-shares-for-sek-7-655-136-a3f806ea 2018-01-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=positive-treatment-results-with-modufolin-r-arfolitixorin-will-be-published-at-a-cancer-congress-asco-in-the-us-6b7960f2 2018-01-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=successful-end-of-phase-2-meeting-with-fda-and-phase-3-program-for-modufolin-r-agreed-53f4ba35 2018-01-17 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-reports-positive-efficacy-data-for-modufolin-r-arfolitixorin-from-patients-treated-for-metastatic-colorectal-cancer-34a35a78 2018-01-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-to-present-at-the-10th-annual-biotech-showcase-conference-0986a77c 2018-01-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-an-abstract-regarding-modufolins-r-efficacy-in-colorectal-cancer-treatment-will-be-presented-at-asco-gi-2018-3f49c1fe 2017-11-27 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-appoints-gustaf-albert-as-chief-financial-officer-4a59d5b4 2017-10-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-modufolin-r-as-a-rescue-therapy-in-the-treatment-of-osteosarcoma-in-children-is-safe-and-preventive-of-hdmtx-toxicities-e5d99c12 2017-09-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-announces-successful-type-c-meeting-with-fda-regarding-its-drug-candidate-modufolin-r-for-treatment-of-metastatic-colorectal-cancer-e6126d16 2017-09-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=from-the-ongoing-iso-cc-005-study-isofol-reports-initial-indications-of-efficacy-of-modufolin-r-in-patients-with-metastatic-colorectal-cancer-501fb764 2017-08-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-appoints-sven-erickson-as-chief-commercial-officer-6e510216 2017-08-18 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-establish-cooperation-with-prof-sten-nilsson-and-dr-alain-herrera-in-preparation-for-the-upcoming-pivotal-trial-with-modufolin-r-e08974e8 2017-08-16 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-that-an-abstract-about-modufolin-r-in-osteosarcoma-treatment-will-be-presented-at-esmo-2017-fece809b 2017-07-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=scrip-intelligence-a-leading-source-of-news-and-strategic-analysis-for-the-global-pharmaceutical-industry-publish-article-about-isofol-medical-ed8dfdeb 2017-07-20 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-has-enrolled-and-dosed-its-first-group-of-patients-in-the-ind-study-iso-ff-001-fd631fa3 2017-07-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=new-scientific-findings-strengthen-rationale-and-motivation-for-isofol-medical-to-conduct-the-pivotal-iso-cc-007-study-828722c7 2017-07-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-has-initiated-five-additional-study-sites-in-the-iso-cc-005-study-in-which-modufolin-r-is-evaluated-in-colorectal-cancer-4ab75736 2017-06-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-publication-of-an-abstract-for-the-2017-asco-annual-meeting-719ec8e0 2017-05-22 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=pareto-securities-has-notified-isofol-medical-ab-that-stabilisation-measures-regarding-the-companys-shares-have-been-taken-a5517b42 2017-05-05 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-accepted-for-presentation-of-abstract-at-the-2017-asco-annual-meeting-5be18ab5 2017-05-03 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=pareto-securities-has-notified-isofol-medical-ab-publ-that-stabilisation-measures-regarding-the-companys-shares-have-been-taken-a92d4931 2017-04-25 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=pareto-securities-has-notified-isofol-medical-ab-that-stabilisation-measures-regarding-the-companys-shares-have-been-taken-11ba97a9 2017-04-12 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-has-successfully-completed-the-iso-mtx-003-study-in-which-modufolin-r-is-evaluated-as-rescue-therapy-b8d36dbd 2017-04-11 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-largest-shareholder-and-co-founder-acquires-shares-in-the-company-7b7fdfaf 2017-04-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofols-chairman-of-the-board-acquires-shares-in-the-company-060d9f56 2017-04-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-announces-the-outcome-of-the-offering-trading-on-nasdaq-first-north-premier-commences-today-3921c424 2017-04-04 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-isofol-will-present-its-contemplated-ipo-in-stockholm-on-march-29-9a570eda 2017-03-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=invitation-isofol-will-present-its-contemplated-ipo-in-goteborg-on-march-22-c8d4046a 2017-03-21 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=listing-of-isofol-medical-on-nasdaq-first-north-premier-and-publication-of-prospectus-309dcd9b 2017-03-20 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-announces-its-intention-to-list-on-nasdaq-first-north-premier-b18a1c04 2017-03-13 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-files-important-new-us-patent-application-677a1e47 2017-02-20 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=fda-clears-isofols-ind-application-to-start-clinical-program-within-colorectal-cancer-with-modufolin-r-8f07b72d 2017-01-24 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-present-at-aktietorget-investor-meeting-d87f07a6 2016-10-07 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-has-successfully-advanced-to-the-next-dose-level-of-modufolin-r-in-a-phase-i-ii-clinical-trial-in-colorectal-cancer-0aa2386c 2016-06-02 https://investornews.isofolmedical.com/en/press-releases/artikel?slug=isofol-medical-share-issue-oversubscribed-securing-over-sek-39-million-to-strengthen-the-ongoing-phase-ii-clinical-development-program-of-modufolin-r-88b14482 2016-03-14